KEY FEATURES
Full Name | Calreticulin |
---|---|
Synonym | CRT; RO; SSA; CC1qR; ERp60; HACBP; grp60; CRTC; CRP55; Calregulin; Sicca Syndrome Antigen A; Autoantigen Ro; Endoplasmic reticulum resident protein 60 |
Assay Type | Sandwich |
Reactivity | Human |
Range | 3.12-200ng/mL |
Sensitivity | 1.22ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human CALR in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CALR. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CALR and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CALR, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CALR. You can calculate the concentration of Human CALR in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CALR ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 9.56 | 19.21 | 76.98 | 9.58 | 20.12 | 72.53 |
Standard deviation | 0.62 | 1.06 | 2.44 | 0.55 | 0.85 | 2.85 |
CV(%) | 6.48 | 5.54 | 3.17 | 5.71 | 4.23 | 3.93 |
RECOVERY
The recovery of Human CALR spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 92-104 | 98 |
EDTA plasma (n=8) | 87-100 | 92 |
Cell culture media (n=8) | 95-108 | 100 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CALR in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CRT ELISA Kits
PDIA3 ELISA Kit | publications with CRT and PDIA3 |
PLAT ELISA Kit | publications with CRT and PLAT |
NKX2-1 ELISA Kit | publications with CRT and NKX2-1 |
FBN1 ELISA Kit | publications with CRT and FBN1 |
Pathways associated with CRT ELISA Kit
Activation Of Chaperone Genes By ATF6-alpha Pathway | Activation Of Chaperone Genes By ATF6-alpha Pathway |
Activation Of Chaperones By ATF6-alpha Pathway | Activation Of Chaperones By ATF6-alpha Pathway |
Adaptive Immune System Pathway | Adaptive Immune System Pathway |
Androgen Receptor Signaling Pathway | Androgen Receptor Signaling Pathway |
Antigen Presentation: Folding, Assembly And Peptide Loading Of Class I MHC Pathway | Antigen Presentation: Folding, Assembly And Peptide Loading Of Class I MHC Pathway |
Antigen Processing And Presentation Pathway | Antigen Processing And Presentation Pathway |
Antigen Processing-Cross Presentation Pathway | Antigen Processing-Cross Presentation Pathway |
Asparagine N-linked Glycosylation Pathway | Asparagine N-linked Glycosylation Pathway |
Assembly Of Viral Components At The Budding Site Pathway | Assembly Of Viral Components At The Budding Site Pathway |
Diseases associated with CRT ELISA Kit
Neoplasms | publications with CRT and Neoplasms |
Cognition Disorders | publications with CRT and Cognition Disorders |
Disease Models, Animal | publications with CRT and Disease Models, Animal |
Carcinoma, Hepatocellular | publications with CRT and Carcinoma, Hepatocellular |
Liver Diseases | publications with CRT and Liver Diseases |
Liver Neoplasms | publications with CRT and Liver Neoplasms |
Fatty Liver | publications with CRT and Fatty Liver |
Prenatal Exposure Delayed Effects | publications with CRT and Prenatal Exposure Delayed Effects |
Inflammation | publications with CRT and Inflammation |
Necrosis | publications with CRT and Necrosis |
Organs/Tissues associated with CRT ELISA Kit
Brain | publications with CRT and Brain |
Nerve | publications with CRT and Nerve |
Intestine | publications with CRT and Intestine |
Blood | publications with CRT and Blood |
Ganglia | publications with CRT and Ganglia |
Kidney | publications with CRT and Kidney |
Eye | publications with CRT and Eye |
Muscle | publications with CRT and Muscle |
Liver | publications with CRT and Liver |
Embryonic Tissue | publications with CRT and Embryonic Tissue |